Claims for Patent: 6,541,207

Summary for Patent: 6,541,207

Title:	Methods for generating recombined polynucleotides
Abstract:	A method for in vitro construction of a library of recombined homologous polynucleotides from a number of different starting DNA templates and primers by induced template shifts during an polynucleotide synthesis is described, whereby A. extended primers are synthesized by a) denaturing the DNA templates b) annealing primers to the templates, c) extending the said primers by use of a polymerase, d) stop the synthesis, and e) separate the extended primers from the templates, B. a template shift is induced by a) isolating the extended primers from the templates and repeating steps A.b) to A.e) using the extended primers as both primers and templates, or b) repeating steps A.b) to A.e), C. this process is terminated after an appropriate number of cycles of process steps A. and B.a), A. and B.b), or combinations thereof. Optionally the polynucleotides are amplified in a standard PCR reaction with specific primers to selectively amplify homologous polynucleotides of interest.
Inventor(s):	Vind; Jesper (V.ae butted.rl.o slashed.se, DK), Borchert; Torben Vedel (.O slashed.sterbro, DK)
Assignee:	Novozymes A/S (Bagsvaerd, DK)
Application Number:	09/687,301
Patent Claims:	1. A method of shuffling polynucleotides, comprising: (a) shuffling first strands of a first population of polynucleotides with second strands of a second population of polynucleotides, without shuffling second strands of the first population and first strands of the second population; and (b) synthesizing strands complementary to the shuffled first strands to form shuffled duplex polynucleotides. 2. The method of claim 1, wherein the first strands are isolated from the second strands by labeling the first strands with biotin. 3. The method of claim 1, wherein the first strands are a pool of polynucleotides comprising diverse forms of a polynucleotide. 4. The method of claim 3, wherein the diverse forms of the polynucleotide are from naturally occurring organisms of different species. 5. The method of claim 3, wherein the pool of polynucleotides exhibit more than 50% sequence identity. 6. The method of claim 3, wherein the pool of polynucleotides exhibit more than 70% sequence identity. 7. The method of claim 3, wherein the pool of polynucleotides exhibit more than 90% sequence identity. 8. The method of claim 3, wherein the pool of polynucleotides exhibit more than 95% sequence identity. 9. The method of claim 1, wherein the first strands are contacted with at least one completely random primer. 10. The method of claim 1, wherein the first strands are contacted with at least one partly random primer or at least a pair of partly random primers. 11. A method of identifying polypeptides exhibiting a desired property, comprising the method of claim 1, further comprising expressing and screening polypeptides encoded by the shuffled duplex polynucleotides for a desired property. 12. The method of claim 11, wherein the property is an enzymatic activity. 13. The method of claim 11, wherein at least one extension cycle is conducted under conditions of incomplete elongation. 14. The method of claim 11, wherein the first population of polynucleotides encode variant forms of an enzyme. 15. The method of claim 14, wherein the enzyme is selected from the group consisting of carbonyl hydrolase, carbohydrase, an esterase, a protease, a lipase, an amylase, a cellulase, an oxidase, and an oxido reductase. 16. The method of claim 11, wherein the frist population of polynucleotides comprises at least two variant polynucleotides and wherein the variant polynucleotides encode a polypeptide selected from the group consisting of insulin, ACTH, glucagon, somatostatin, somatotropin, thymosin, parathyroid hormone, pituary hormones, somatomedin, erythropoietin, luteinizing hormone, chorionic gonadotropin, hypothalamic releasing factors, antidiuretic hormones, thyroid stimulating hormone, relaxin, interferon, thrombopoeitin (TPO) and prolactin. 17. A method of shuffling polynucleotides, comprising: (a) isolating first strands of a first population of polynucleotides from second strands of the first population of polynucleotides and isolating first strands of a second population of polynucleotides from second strands of the second population of polynucleotides; (b) shuffling first strands of the first population of polynucleotides with second strands of the second population of polynucleotides, without shuffling second strands of the first population of polynucleotides and first strands of the second population of polynucleotides; (c) synthesizing strands complementary to the shuffled first strands to form shuffled duplex polynucleotides. 18. The method of claim 17, wherein the first strands are isolated from the second strands by labeling the first strands with biotin. 19. The method of claim 17, wherein the first strands are a pool of polynucleotides comprising diverse forms of a polynucleotide. 20. The method of claim 19, wherein the diverse forms of the polynucleotide are from naturally occurring organisms of different species. 21. The method of claim 17, wherein the pool of polynucleotides exhibit more than 50% sequence identity. 22. The method of claim 17, wherein the pool of polynucleotides exhibit more than 70% sequence identity. 23. The method of claim 17, wherein the pool of polynucleotides exhibit more than 90% sequence identity. 24. The method of claim 19, wherein the pool of polynucleotides exhibit more than 95% sequence identity. 25. A method of identifying polypeptides exhibiting a desired property, comprising the method of claim 4, further comprising expressing and screening polypeptides encoded by the shuffled duplex polynucleotides for a desired property. 26. The method of claim 25, wherein the property is an enzymatic activity. 27. The method of claim 25, wherein at least one extension cycle is conducted under conditions of incomplete elongation. 28. The method of claim 25, wherein the first population of polynucleotides encode variant forms of an enzyme. 29. The method of claim 28, wherein the enzyme is selected from the group consisting of carbonyl hydrolase, carbohydrase, an esterase, a protease, a lipase, an amylase, a cellulase, an oxidase, and an oxido reductase. 30. The method of claim 25, wherein the first population of polynucleotides comprises at least two variant polynucleotides and wherein the variant polynucleotides encode a polypeptide selected from the group consisting of insulin, ACTH, glucagon, somatostatin, somatotropin, thymosin, parathyroid hormone, pituary hormones, somatomedin, erythropoietin, luteinizing hormone, chorionic gonadotropin, hypothalamic releasing factors, antidiuretic hormones, thyroid stimulating hormone, relaxin, interferon, thrombopoeitin (TPO) and prolactin.

Details for Patent 6,541,207

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	01/15/1974		2017-03-18
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	12/27/1984		2017-03-18
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	02/15/1985		2017-03-18
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	02/16/1990		2017-03-18
Bel-mar Laboratories, Inc.	CHORIONIC GONADOTROPIN	chorionic gonadotropin	Injection	017054	03/26/1974		2017-03-18
Fresenius Kabi Usa, Llc	CHORIONIC GONADOTROPIN	chorionic gonadotropin	For Injection	017067	03/05/1973		2017-03-18
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2017-03-18